“A class action suit can be initiated into the matter if a complaint is made to NCDRC,” consumer affairs minister Ram Vilas Paswan said on Friday.
Read more from our special coverage on "NESTLE MAGGI CONTROVERSY"
The Uttar Pradesh Food and Drug Administration (FDA) is also filing a case against Nestle India at a district court at Barabanki, from where it had collected the “contaminated” samples, UP FDA additional commissioner (administration) Ram Araj Maurya told Business Standard on Friday. Barabanki FDA designated officer V K Pandey confirmed they have completed preliminary homework to present a case before the court.
The UP FDA continues to collect random Maggi samples for investigation. So far, it has collected about a dozen samples from Lucknow and is checking if these are ‘clean’. “The reports of three such samples have come and they have tested negative. Reports of the remaining samples are awaited,” Maurya said. There are six FDA labs in UP at Lucknow, Gorakhpur, Meerut, Varanasi, Agra and Jhansi.
Last month, the UP FDA had asked Nestle India to withdraw a batch of Maggi noodles "manufactured in February 2014" after it said it had found high levels of added MSG, a taste enhancer, in the noodles and lead beyond permissible limits.
‘Class-action suits on firms misleading consumers’
The Union consumer affairs ministry said it would lodge class-action suits against companies against which complaints of misleading advertisements are filed. The ministry has received 116 complaints of violation of consumer rights since it launched its website. Of these, 27 are related to health, 24 are related to education and nine are related to real estate.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app